138 related articles for article (PubMed ID: 10746020)
1. [Adverse effects of administration of intravenous human immunoglobulins].
Bednarík J; Kadanka Z
Cas Lek Cesk; 1999 Nov; 138(21):647-9. PubMed ID: 10746020
[TBL] [Abstract][Full Text] [Related]
2. Safety of intravenous immunoglobulin (IVIG) therapy.
Katz U; Achiron A; Sherer Y; Shoenfeld Y
Autoimmun Rev; 2007 Mar; 6(4):257-9. PubMed ID: 17317619
[TBL] [Abstract][Full Text] [Related]
3. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
4. Intravenous immunoglobulin: adverse effects and safe administration.
Orbach H; Katz U; Sherer Y; Shoenfeld Y
Clin Rev Allergy Immunol; 2005 Dec; 29(3):173-84. PubMed ID: 16391392
[TBL] [Abstract][Full Text] [Related]
5. [The use of intravenous immunoglobulins in the treatment of primary immunodeficiencies].
Lewandowicz-Uszyńska A; Jankowski A
Pol Merkur Lekarski; 2011 Jun; 30(180):409-12. PubMed ID: 21751549
[TBL] [Abstract][Full Text] [Related]
6. Not all intravenous immunoglobulin preparations are equally well tolerated.
Feldmeyer L; Benden C; Haile SR; Boehler A; Speich R; French LE; Hofbauer GF
Acta Derm Venereol; 2010 Sep; 90(5):494-7. PubMed ID: 20814625
[TBL] [Abstract][Full Text] [Related]
7. Use of intravenous immunoglobulin G (IVIG).
Looney RJ; Huggins J
Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immunoglobulins in neurological disorders: safety issues.
Eibl MM
Neurol Sci; 2003 Oct; 24 Suppl 4():S222-6. PubMed ID: 14598047
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of intravenous immunoglobulin.
Misbah SA; Chapel HM
Drug Saf; 1993 Oct; 9(4):254-62. PubMed ID: 8260119
[TBL] [Abstract][Full Text] [Related]
10. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
Emmi L; Chiarini F
Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
[TBL] [Abstract][Full Text] [Related]
11. Acute renal failure, translocational hyponatremia and hyperkalemia following intravenous immunoglobulin therapy.
Daphnis E; Stylianou K; Alexandrakis M; Xylouri I; Vardaki E; Stratigis S; Kyriazis J
Nephron Clin Pract; 2007; 106(4):c143-8. PubMed ID: 17596722
[TBL] [Abstract][Full Text] [Related]
12. Side effects of intravenous immunoglobulins in neurological autoimmune disorders--a prospective study.
Stangel M; Kiefer R; Pette M; Smolka MN; Marx P; Gold R
J Neurol; 2003 Jul; 250(7):818-21. PubMed ID: 12883923
[TBL] [Abstract][Full Text] [Related]
13. Severe eczematous skin reaction after high-dose intravenous immunoglobulin infusion: report of 4 cases and review of the literature.
Vecchietti G; Kerl K; Prins C; Kaya G; Saurat JH; French LE
Arch Dermatol; 2006 Feb; 142(2):213-7. PubMed ID: 16490849
[TBL] [Abstract][Full Text] [Related]
14. Side-effects of intravenous immune globulins.
Duhem C; Dicato MA; Ries F
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
[TBL] [Abstract][Full Text] [Related]
15. Adverse events associated with intravenous immunoglobulin therapy.
Hamrock DJ
Int Immunopharmacol; 2006 Apr; 6(4):535-42. PubMed ID: 16504916
[TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin-associated cranial pachymeningitis.
Marie I; Hervé F; Lahaxe L; Robaday S; Gerardin E; Levesque H
J Intern Med; 2006 Aug; 260(2):164-7. PubMed ID: 16882281
[TBL] [Abstract][Full Text] [Related]
17. [Intravenous immunoglobulins in the treatment of glomerulopathies].
Floccari F; Palla R; Polito P; Campo S; Aloisi C; Buemi M
G Ital Nefrol; 2007; 24(4):311-9. PubMed ID: 17659502
[TBL] [Abstract][Full Text] [Related]
18. [Use of high dose intravenous immunoglobulin in neurologic disease].
Korsak J; Zaleska B; Orłowska E; Kotowicz J
Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039
[TBL] [Abstract][Full Text] [Related]
19. Acute ST elevation myocardial infarction during intravenous immunoglobulin infusion.
Barsheshet A; Marai I; Appel S; Zimlichman E
Ann N Y Acad Sci; 2007 Sep; 1110():315-8. PubMed ID: 17911446
[TBL] [Abstract][Full Text] [Related]
20. Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature.
Marie I; Maurey G; Hervé F; Hellot MF; Levesque H
Br J Dermatol; 2006 Oct; 155(4):714-21. PubMed ID: 16965420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
